World-Class Liver & Biliary Surgery in Shanghai
The Department of Hepatobiliary Surgery at Fudan University's Zhongshan Hospital is one of China's most prestigious surgical centers, with a legacy spanning decades of clinical innovation and patient care. Recognized nationally and internationally for its expertise in liver cancer, liver transplantation, and complex biliary surgery, the department attracts patients from across China and around the world.
For international patients, accessing China's top-tier hospitals can be daunting — language barriers, unfamiliar systems, and complex logistics often stand in the way of receiving the care you need. China Medical Concierge Shanghai (CMCS) exists to remove those barriers. We coordinate every aspect of your medical journey, from initial inquiry to post-treatment follow-up, so you can focus entirely on your health.
About the Department
Zhongshan Hospital's hepatobiliary surgery department is affiliated with Fudan University School of Medicine, one of China's top medical institutions. The department operates as a national key clinical specialty and is home to some of China's most accomplished liver surgeons and transplant specialists.
The department performs thousands of hepatobiliary procedures annually, including one of the highest volumes of liver transplants in Asia. Its multidisciplinary approach integrates surgery, interventional radiology, medical oncology, hepatology, and pathology — ensuring every patient receives a comprehensive, personalized treatment plan.
Clinical research is deeply embedded in the department's culture. Active participation in national and international clinical trials means patients at Zhongshan often have access to cutting-edge therapies not yet widely available elsewhere.
Conditions Treated
The department manages a broad spectrum of hepatobiliary and pancreatic conditions, including:
- Hepatocellular Carcinoma (HCC) — Primary liver cancer at all stages, from early resectable disease to advanced cases requiring multimodal therapy
- Liver Metastases — Secondary liver tumors originating from colorectal, gastric, breast, lung, and other primary cancers
- Intrahepatic & Perihilar Cholangiocarcinoma — Bile duct cancers requiring complex surgical resection and biliary reconstruction
- Gallbladder Cancer — Radical cholecystectomy and oncological staging
- Gallstones & Cholecystitis — Laparoscopic cholecystectomy and management of complicated biliary stone disease
- Benign Liver Tumors — Hemangioma, focal nodular hyperplasia (FNH), hepatic adenoma, and liver cysts
- Liver Abscesses — Pyogenic and amoebic liver abscess, including hydatid (echinococcal) disease
- End-Stage Liver Disease — Liver transplantation for hepatitis B/C-related cirrhosis, alcoholic liver disease, autoimmune hepatitis, and metabolic liver conditions
- Portal Hypertension — Surgical and interventional management of variceal bleeding, ascites, and hypersplenism
- Pancreatic Tumors — Pancreatic ductal adenocarcinoma, cystic neoplasms, and neuroendocrine tumors requiring Whipple procedure or distal pancreatectomy
- Periampullary Tumors — Tumors of the ampulla of Vater and duodenum
- Biliary Strictures & Injuries — Post-surgical biliary complications and iatrogenic bile duct injuries
Leading Specialists
Prof. Fan Jia (樊嘉) — Academician, Chinese Academy of Sciences
Prof. Fan Jia is widely regarded as one of China's foremost liver surgeons and a global authority on hepatocellular carcinoma and liver transplantation. Elected as an Academician of the Chinese Academy of Sciences — the highest academic honor in China — Prof. Fan has dedicated his career to advancing the surgical and oncological management of liver cancer.
Under his leadership, Zhongshan's liver transplant program has grown into one of the largest and most successful in Asia, performing over 500 transplants per year with survival outcomes comparable to the world's leading transplant centers. Prof. Fan's research team has made landmark contributions to understanding HCC recurrence mechanisms, developing novel biomarkers for early detection, and pioneering liquid biopsy technologies for liver cancer screening.
He has published extensively in top-tier international journals including Nature Medicine, Journal of Clinical Oncology, and Hepatology, and serves on the editorial boards of multiple leading hepatology publications. For patients with complex liver cancer or end-stage liver disease, Prof. Fan's team represents one of the best options available anywhere in the world.
Prof. Zhou Jian (周俭) — Deputy Director, Hepatobiliary Surgery
Prof. Zhou Jian is a leading expert in minimally invasive hepatic surgery and a pioneer in laparoscopic liver resection techniques in China. As Deputy Director of the department, he oversees a high-volume surgical program and is particularly recognized for his work in anatomical liver resection, intraoperative ultrasound guidance, and strategies to minimize blood loss during complex hepatic procedures.
Prof. Zhou has been instrumental in developing evidence-based protocols for adjuvant therapy following liver cancer surgery, significantly improving long-term recurrence-free survival rates for his patients. He is a frequent invited speaker at international hepatobiliary surgery congresses and has trained numerous surgeons from across China and abroad.
His clinical focus includes patients with multifocal HCC, tumors in difficult anatomical locations (segments 7, 8, and the caudate lobe), and cases requiring repeat hepatectomy for recurrent disease.
Treatment Approaches & Technology
Zhongshan's hepatobiliary team employs a full spectrum of evidence-based treatment modalities, individually tailored to each patient's diagnosis, disease stage, liver function, and overall health status:
Surgical Treatments
- Open Liver Resection — Major hepatectomy including right/left hemihepatectomy, trisectionectomy, and extended resections with vascular reconstruction
- Laparoscopic Liver Resection — Minimally invasive resection for tumors in favorable anatomical positions, offering faster recovery and reduced complications
- Robotic-Assisted Hepatectomy — For select complex cases requiring enhanced dexterity and precision
- Liver Transplantation — Both living donor liver transplantation (LDLT) and deceased donor transplantation, with a dedicated transplant coordination and immunosuppression management team
- Bile Duct Resection & Reconstruction — Complex biliary surgery including hepaticojejunostomy and biliary-enteric anastomosis
- Pancreaticoduodenectomy (Whipple Procedure) — For periampullary and pancreatic head tumors
Interventional & Ablative Treatments
- Transarterial Chemoembolization (TACE) — Catheter-based delivery of chemotherapy directly to liver tumors, cutting off their blood supply
- Drug-Eluting Bead TACE (DEB-TACE) — Enhanced TACE with sustained drug release for improved tumor response
- Hepatic Arterial Infusion Chemotherapy (HAIC) — High-dose regional chemotherapy via hepatic artery catheter for advanced HCC
- Radiofrequency Ablation (RFA) — Image-guided thermal ablation for small liver lesions (<3cm)
- Microwave Ablation (MWA) — Faster and more powerful ablation for larger or multiple lesions
- Portal Vein Embolization (PVE) — Pre-operative procedure to increase future liver remnant volume before major resection
Systemic & Combination Therapies
- Targeted Therapy — Sorafenib, lenvatinib, regorafenib, and other approved agents for advanced HCC
- Immunotherapy — PD-1/PD-L1 checkpoint inhibitors (atezolizumab + bevacizumab, sintilimab, camrelizumab) as first-line or combination therapy
- Conversion Therapy — Downstaging initially unresectable tumors to achieve surgical resectability through combined systemic and locoregional treatment
- Clinical Trials — Access to investigational therapies through Zhongshan's active research program
Multidisciplinary Tumor Board (MDT)
Every complex hepatobiliary case at Zhongshan is reviewed by a dedicated Multidisciplinary Team (MDT) comprising hepatobiliary surgeons, interventional radiologists, medical oncologists, hepatologists, pathologists, and radiologists. This collaborative approach ensures that treatment decisions are evidence-based, comprehensive, and tailored to the individual patient — rather than driven by a single specialty's perspective.
For international patients, CMCS can facilitate remote MDT participation, allowing your case to be reviewed by Zhongshan's specialists before you travel to Shanghai.
Why International Patients Choose Zhongshan
- Unmatched Volume & Experience — One of Asia's highest-volume liver surgery and transplant programs, with outcomes data published in peer-reviewed international journals
- Academic & Research Leadership — Affiliated with Fudan University, with active clinical trials providing access to next-generation therapies
- Integrated Multidisciplinary Care — Seamless coordination across surgery, oncology, radiology, and hepatology under one roof
- Advanced Technology — State-of-the-art operating theaters, intraoperative imaging, and robotic surgical systems
- Cost-Effectiveness — World-class outcomes at a fraction of the cost compared to equivalent care in the United States, United Kingdom, or Australia
- International Patient Pathways — Dedicated support for overseas patients, with priority scheduling and English-language coordination through CMCS
The CMCS Patient Journey
For international patients working with China Medical Concierge Shanghai, the process is designed to be seamless from first contact to final follow-up:
- Initial Inquiry — Contact CMCS with your diagnosis, imaging reports, and medical history. All information is handled with strict confidentiality.
- Medical Record Review — Our team translates and prepares your records for specialist pre-consultation review at Zhongshan Hospital.
- Specialist Matching — We identify the most appropriate specialist based on your specific condition and treatment needs.
- Priority Appointment Scheduling — We secure a consultation with your chosen specialist, bypassing standard waiting times where possible.
- Travel & Logistics Support — Assistance with visa letters, accommodation recommendations, and airport transfers in Shanghai.
- On-Site Concierge — Our bilingual coordinators accompany you to the hospital, managing registration, translation, and real-time communication with your medical team.
- Treatment Coordination — Full management of admission, surgical scheduling, pre-operative testing, and inpatient support.
- Post-Treatment Follow-Up — Medical record translation, remote follow-up coordination, and ongoing communication with your home physician after you return.
Book a Consultation
If you or a loved one is facing a liver, biliary, or pancreatic condition and seeking expert care in Shanghai, CMCS can arrange a specialist consultation with Zhongshan Hospital's hepatobiliary team — with full translation, coordination, and concierge support at every step.
📧 contract@medicalsh.com
💬 WhatsApp: https://wa.me/message/3AM6KAGCW2BAD1
🌐 www.medicalsh.com
0 Kommentare